Higher expression of RHOB and HLA-DPA1 and lower expression of TALDO1 and TKT in tumors correlated with significantly longer overall survival (OS) in patients with HCC (Figure 6F). The gene discussed is TALDO1; the disease is hepatocellular carcinoma.